Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerry O Cleveland

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Hospital Pharmacy|August 4, 2020
Fidaxomicin Compared With Oral Vancomycin for the Treatment of Severe <i>Clostridium difficile-</i>Associated Diarrhea: A Retrospective ReviewBryant B Summers, Mary Yates, Kerry O Cleveland, et al.
AIDS (London, England)|May 6, 2009
Trichosporon asahii infection in an HIV-positive patientRandy O Odero, Alexandre Lacasse, Shirin Mazumder, et al.
Pharmacy (Basel, Switzerland)|April 27, 2023
Leveling Up: Evaluation of IV v. PO Linezolid Utilization and Cost after an Antimicrobial Stewardship Program Revision of IV to PO Conversion Criteria within a Healthcare SystemJessica Jaggar, Kerry O Cleveland, Jennifer D Twilla, et al.
The American Journal of the Medical Sciences|October 22, 2015
Meningoencephalitis Following Ipilimumab Administration in Metastatic MelanomaMatthew K Stein, Bryant B Summers, Christine A Wong, et al.
Journal of Global Antimicrobial Resistance|November 17, 2021
A retrospective, multicentre evaluation of eravacycline utilisation in community and academic hospitalsAthena L V Hobbs, Michael S Gelfand, Kerry O Cleveland, et al.
Drugs - Real World Outcomes|May 7, 2020
Clinical Experience with Telavancin for the Treatment of Patients with Bacteremia and Endocarditis: Real-World Results from the Telavancin Observational Use Registry (TOUR™)Joseph Reilly, Micah A Jacobs, Bruce Friedman, et al.
Annals of Clinical Microbiology and Antimicrobials|March 16, 2016
Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORER Andrew Seaton, Armando Gonzalez-Ruiz, Kerry O Cleveland, et al.
The Journal of Antimicrobial Chemotherapy|August 18, 2011
Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infectionsS Travis King, Justin B Usery, Katherine Holloway, et al.
The American Journal of the Medical Sciences|September 19, 2014
Evaluation of the treatment of methicillin-resistant Staphylococcus aureus bacteremiaJustin B Usery, Ngan H Vo, Christopher K Finch, et al.
Pharmacy (Basel, Switzerland)|April 27, 2023
Residual Infusion Performance Evaluation (RIPE): A Single-Center Evaluation of Residual Volume Post-Intravenous Eravacycline InfusionAlysa J Baumann, Kerry O Cleveland, Michael S Gelfand, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Hospital Pharmacy|August 4, 2020
Fidaxomicin Compared With Oral Vancomycin for the Treatment of Severe <i>Clostridium difficile-</i>Associated Diarrhea: A Retrospective ReviewBryant B Summers, Mary Yates, Kerry O Cleveland, et al.
AIDS (London, England)|May 6, 2009
Trichosporon asahii infection in an HIV-positive patientRandy O Odero, Alexandre Lacasse, Shirin Mazumder, et al.
Pharmacy (Basel, Switzerland)|April 27, 2023
Leveling Up: Evaluation of IV v. PO Linezolid Utilization and Cost after an Antimicrobial Stewardship Program Revision of IV to PO Conversion Criteria within a Healthcare SystemJessica Jaggar, Kerry O Cleveland, Jennifer D Twilla, et al.
The American Journal of the Medical Sciences|October 22, 2015
Meningoencephalitis Following Ipilimumab Administration in Metastatic MelanomaMatthew K Stein, Bryant B Summers, Christine A Wong, et al.
Journal of Global Antimicrobial Resistance|November 17, 2021
A retrospective, multicentre evaluation of eravacycline utilisation in community and academic hospitalsAthena L V Hobbs, Michael S Gelfand, Kerry O Cleveland, et al.
Drugs - Real World Outcomes|May 7, 2020
Clinical Experience with Telavancin for the Treatment of Patients with Bacteremia and Endocarditis: Real-World Results from the Telavancin Observational Use Registry (TOUR™)Joseph Reilly, Micah A Jacobs, Bruce Friedman, et al.
Annals of Clinical Microbiology and Antimicrobials|March 16, 2016
Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORER Andrew Seaton, Armando Gonzalez-Ruiz, Kerry O Cleveland, et al.
The Journal of Antimicrobial Chemotherapy|August 18, 2011
Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infectionsS Travis King, Justin B Usery, Katherine Holloway, et al.
The American Journal of the Medical Sciences|September 19, 2014
Evaluation of the treatment of methicillin-resistant Staphylococcus aureus bacteremiaJustin B Usery, Ngan H Vo, Christopher K Finch, et al.
Pharmacy (Basel, Switzerland)|April 27, 2023
Residual Infusion Performance Evaluation (RIPE): A Single-Center Evaluation of Residual Volume Post-Intravenous Eravacycline InfusionAlysa J Baumann, Kerry O Cleveland, Michael S Gelfand, et al.
Pageof 7